Nothing new discussed however they were still extremely confident of a positive CE Mark determination. While the Brexit machinations have no bearing on the Oncolsil certificate when issued, there was a sense that the overall workload imosed on BSI by Brexit has slowed down the Oncosil review. Also some good clarification on the resection rates/R0 rates compared to literature review which suggests that resection rate with same chemo drugs alone c15% vs. 24% combined with Oncosil. Directors expected 4-5 resections (10%) heading into the study. This bodes well for redesigning the pivotal study in the US to potential cover different endpoint(s) and reduce sample size
- Forums
- ASX - By Stock
- Investor call
Nothing new discussed however they were still extremely...
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.61M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $2.602K | 578.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
47 | 27372830 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 31911866 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
47 | 27372830 | 0.004 |
14 | 9805263 | 0.003 |
6 | 5657526 | 0.002 |
4 | 7600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 31911866 | 17 |
0.006 | 16593590 | 18 |
0.007 | 28338316 | 22 |
0.008 | 2147500 | 6 |
0.009 | 1217500 | 2 |
Last trade - 11.26am 14/05/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |